QUSVM
Qiming U.S. Ventures Management Portfolio holdings
AUM
$23.6M
This Quarter Return
+54.48%
1 Year Return
-18.39%
3 Year Return
+715.34%
5 Year Return
–
10 Year Return
–
AUM
$82.6M
AUM Growth
+$82.6M
(+9.3%)
Cap. Flow
+$4.83M
Cap. Flow
% of AUM
5.84%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Jasper Therapeutics
JSPR
|
$4.83M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ventyx Biosciences
VTYX
$171M
| $25M | 30.26% | 746,370 | – | – |
|
|
ICVX
2
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $20.4M | 24.64% | 3,510,228 | – | – |
|
|
3
Jasper Therapeutics
JSPR
$45.5M
| $15.4M | 18.66% | 8,519,648 +2,666,666 | +46% | +$4.83M |
|
4
HilleVax
HLVX
$105M
| $9.24M | 11.18% | 558,923 | – | – |
|
5
Tourmaline Bio
TRML
$601M
| $5.51M | 6.67% | 2,932,606 | – | – |
|
|
ELEV
6
DELISTED
Elevation Oncology
ELEV
| $4.5M | 5.45% | 2,370,142 | – | – |
|
7
Kezar Life Sciences
KZR
$28.9M
| $2.59M | 3.14% | 828,711 | – | – |
|